Fonterra inks deal with UK firm

NIKO KLOETEN
Last updated 09:27 04/07/2014

Relevant offers

Dairy

Fonterra urged to build on mozzarella success Keith Woodford: Learning from Tillamook dairy Grandparenting rule in plan change will reward polluters Water quality, emissions and public perception hot topics for dairy in election year Cow sells for $6000 as top Taranaki herd goes under hammer Okaiawa couple grow Taranaki's top fodder beet crop to win trophy last awarded 100 years ago Southern hemisphere farmers will struggle to meet milk demand growth over next five years Fonterra expected to offer prudent 2017-18 forecast Dairy demonstration operation Owl Farm finishes strongly after a taxing season Innovative milk chiller being snapped up by dairy farmers

Fonterra has signed a five-year deal to market and sell two infant formula ingredients made by British-based Dairy Crest.

The products, a prebiotic called galacto-oligosaccharide (GOS) and demineralised whey, are both used in the manufacture of infant formulas.

Fonterra will be the exclusive sales channel for the infant formula ingredients produced and will receive a commission on the sales.

Dairy Crest is entering into a newly-formed joint venture with British-based Fayrefield Foods to produce the GOS. These factories are expected to begin production next year.

Fonterra chief executive Theo Spierings said the agreement was a win-win for all the companies and each would bring their expertise to the partnership.

He said the deal aligned with Fonterra's strategy to develop a leading position in the global infant-formula market.

"Infant formula is the fastest-growing dairy category in the world," he said.

"Demand is particularly strong in Asia, where China is the leading global infant-formula market."

Fonterra was the centre of a botulism scare last year that sparked a mass recall of whey products before testing revealed it was a false alarm.

The dairy co-operative still faces legal action from French food giant Danone, which has said it lost €350 million (NZ$544m) as a result of the recall.

Ad Feedback

- Stuff

Special offers

Featured Promotions

Sponsored Content